Call us to discuss our Clinical Trials: (386) 898-0547 x 6
or email
Dont Forget: Contact our research staff now about the Clinical Trial that interests you
Clinical Research and Trials


Dr Matt Leavitt, the founder and medical director of Advanced Dermatology and Cosmetic Surgery (ADCS) , has undertaken the challenge of establishing the largest networked clinical research group in the country. At this point, ADCS sees over 450,000 patients per year. Dr Leavitt recognizes that never before has there been an opportunity to provide this many patients access to clinical trials. Nor has there ever been the ability to provide potential access to tens of thousands of patients to those pharmaceutical companies and medical device companies doing clinical studies.

Dr Leavitt has assigned James A Solomon, MD PhD, the Director of Ameriderm Research, the Research Division of ADCS, the task to achieve this goal. The plan is to recruit the entire group of over 98 providers in ADCS either to directly participate in research studies or to identify and refer patients to these studies. Several key sites throughout Florida have been established as primary clinical research centers. These centers include Ormond Beach, Kissimmee, and Jacksonville. Others will follow regionally throughout FL as needed. The remaining ADCS offices will become satellite sites of the clinical research centers which help recruit study patients. The long term plan is to put the entire 450,000 patient population under the umbrella of unified electronic medical records (EMR) which also functions as an IRB –HIPPA approved data base.

In addition to his role as Director of the Ameriderm Research, Dr Solomon holds academic appointments as Assistant Clinical Professor at University of Illinois College of Medicine, Urbana-Champaign (UIUC) as well as Associate Professor at University Central Florida College of Medicine (UCF). Through Leavitt Mangement Group, Ameriderm Research is an approved NIH contractual site. As such, it is planning a series of cooperative projects with these and other universities. Among these projects are to convert the EMR into a researchable data base. Once functional, this data base will expand the number of subjects that can be identified and entered into a variety of NIH sponsored University based clinical studies. . In addition, the access to such multi-factorial data will allow industry to determine what other factors may be contributing to the success or failure of their product Another project being planned is the development of a medical optical device that visualize and interpret real time 3-D virtual in vivo dermatopathology .. Currently, Ameriderm Research is working on a cooperative grant with Wake Forest University to study the safety of in-office dermatological surgery.

The large size of ADCS makes Ameriderm Research a one stop shopping for R&D for new drugs, cosmetics, nutraceuticals, and medical devices. We look forward to working with industry and universities to achieve this clinical medical research goal.